BIOMARKERS CORE

$1,006,678U54FY2014DANIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications, trials & patents

Paper 39441727 Paper 39163905 Paper 38722587 Paper 38365185 Paper 38085266 Paper 37632690 Paper 36933541 Paper 36876989 Paper 36787244 Paper 36638679 Paper 36507903 Paper 36272516 Paper 36208817 Paper 36198098 Paper 35995103 Paper 35870575 Paper 35867992 Paper 35716811 Paper 35704338 Paper 35671553 Paper 35642796 Paper 35531765 Paper 35194829 Paper 35104739 Paper 35051697 Paper 35023564 Paper 34980891 Paper 34958368 Paper 34850185 Paper 34755388 Paper 34192324 Paper 34155662 Paper 34151513 Paper 34067652 Paper 34051544 Paper 33916810 Paper 33754156 Paper 33383351 Paper 33261915 Paper 33220047 Paper 33213974 Paper 33119384 Paper 32921152 Paper 32808033 Paper 32622776 Paper 32598452 Paper 32535010 Paper 32532831 Paper 32391548 Paper 32335031 Paper 32267947 Paper 32102909 Paper 32051197 Paper 32051195 Paper 32027158 Paper 31977040 Paper 31961448 Paper 31867658 Paper 31711874 Paper 31701153 Paper 31628475 Paper 31616939 Paper 31603515 Paper 31542145 Paper 31542129 Paper 31406274 Paper 31254538 Paper 31225625 Paper 31166743 Paper 31140663 Paper 31054904 Paper 31022220 Paper 30896238 Paper 30822286 Paper 30776572 Paper 30608961 Paper 30417034 Paper 30385649 Paper 30343684 Paper 30312443 Paper 30193275 Paper 30109713 Paper 30023460 Paper 29955620 Paper 29890187 Paper 29846147 Paper 29753221 Paper 29718460 Paper 29604326 Paper 29600258 Paper 29504780 Paper 29036300 Trial NCT05320887 Trial NCT03194256 Trial NCT03186911 Trial NCT03185546 Trial NCT02301325 Trial NCT02139930 Trial NCT02019459 Trial NCT01681875

Abstract

The Tobacco Constituent and Biomarker Assessment Core will provide a unique resource for Projects 1-3. Investigators in this Core comprise one of the leading academic laboratories in the world for chemical analysis of tobacco constituents and related metabolites and biomarkers. The following urinary metabolites will be quantified: nicotine equivalents (the total of nicotine, cotinine, and trans-3'-hydroxycotinine and their glucuronides), total NNAL (the total of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides), total NNN (the total of free and glucuronidated N-nitrosonornicotine), mercapturic acids of the volatile carcinogens 1,3-butadiene, benzene, acrolein, crotonaldehyde, and ethylene oxide, and the inflammation and oxidative damage biomarkers 11-?-hydroxy-9,15-dioxo-2,3,4,5-tetranorprostane-1,20-dioic acid (PGE- M) and 9,11,15-trihydroxyprosta-5,13-dien-1-oic acid. We will also quantify the formaldehyde-DNA adduct, /V6-hydroxymethyideoxyadenosine in leukocyte DNA, and minor tobacco alkaloids in urine. These biomarkers will provide crucial information for the research being carried out in Projects 1-3.

View original record on NIH RePORTER →